News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer



8/9/2007 9:40:18 AM

ATLANTA, Aug. 9, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today the appointment of Jack W. Callicutt to the position of Vice President and Chief Financial Officer, effective August 6, 2007.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES